CSET’s Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by the Bulletin of the Atomic Scientists. The article discusses how rapidly advancing biotechnology and AI are reshaping biosecurity, highlighting both the promise of new scientific tools and the need for stronger, adaptive safeguards.

CSET’s Steph Batalis shared her expert analysis in an op-ed published by The National Interest. In her piece, she discusses how proposed federal research funding cuts threaten not only U.S. scientific progress but also the safety and security of biological research. These cuts would weaken the safeguards, oversight, and resources that protect both scientists and the public from accidents and biological threats.

CSET’s Sam Bresnick shared his expert analysis in an op-ed published by Nikkei Asia. In his piece, he explores the evolving role of U.S. technology companies in international security, particularly in times of conflict, and examines the contrast between their decisive support for Ukraine during Russia’s 2022 invasion and the uncertainty surrounding their potential response in a Taiwan-China crisis.

Lauren A. Kahn co-authored an op-ed published by the Council on Foreign Relations alongside Erin D. Dumbacher and Michael C. Horowitz. The piece examines the sweeping national security implications of President Trump’s One, Big Beautiful Bill Act, which significantly boosts U.S. defense spending through an unconventional funding route outside the standard Pentagon budget process.

CSET's Steph Batalis shared her expert analysis in an op-ed published by DefenseOne. In her piece, she highlights how the United States’ faltering response to the ongoing measles outbreak reveals serious vulnerabilities in the nation’s public health and biodefense infrastructure.

Jack Corrigan and Vikram Venkatram shared their expert analysis in an op-ed published by The National Interest. In their piece, they examine the political and legal controversy surrounding the Biden administration’s draft guidance on “march-in rights” under the Bayh-Dole Act, which could allow federal agencies to lower drug prices by reclaiming patents on taxpayer-funded inventions when they are not reasonably accessible to the public.

CSET's Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by The Bulletin of the Atomic Scientists. The article explores discusses the complexities and challenges of screening DNA synthesis orders to prevent misuse of potentially dangerous genetic sequences.

In an article published by The Japan Times that discusses the White House’s push for the Pentagon and U.S. national security agencies to accelerate the adoption of AI technology, CSET Research Fellow, Sam Bresnick, provided his expert insights.

In an article published by Foreign Policy that discusses the recent bilateral meetings between China and the United States, CSET Director of Strategy and Foundational Research Grants, Helen Toner, provided her expert insights.

In the China Watcher newsletter published by Politico, Sam Bresnick offered expert insights into the challenges facing U.S.-China cooperation on artificial intelligence.